Blood Glucose Agents Flashcards

1
Q

How does Insulin regulate blood glucose?

A
  • It is a hormone produced by the BETA cells in the pancreas
  • Released into circulation when blood glucose levels rise
  • Stimulates glycogen synthesis, conversion of lipids into fat stored as adipose tissue, and synthesis of proteins from amino acids
  • Released after meals causing blood glucose levels to fall
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

How does glucagon regulate blood glucose?

A
  • Released from the ALPHA cells of the Pancreas
  • Released when blood glucose levels fall
  • Causes immediate mobilization of glycogen stored in the liver
  • Raises blood glucose levels
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Other processes that regulate blood glucose

A
  • Adipocytes secrete adiponectin, increases insulin sensitivity, decreases release of glucose from the liver, protects blood vessels from inflammation
  • Endocannabinoid receptors keep the body in a state of energy gain to prepare for stressful situations
  • Sympathetic nervous system decreases insulin release, increases release of stored glucose, and increases fat breakdown
  • Corticosteroids decrease insulin sensitivity, increase glucose release, and decrease protein building
  • Growth hormone decreases insulin sensitivity, increases FFAs, increases protein building
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Clinical Signs of Diabetes Mellitus

A
  • Hyperglycemia: Fasting blood glucose > 126mg/dL
  • Glycosuria: sugar in the urine (may appear frothy)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Disorders associated with Diabetes Mellitus

A
  • Atherosclerosis: MIs and CVAs related to the build up of plaques in the vessel lining
  • Retinopathy: loss of vision as tiny vessels in the eye are narrowed and closed
  • Neuropathies: Oxygen is cut off to feet and legs, progressive changes to nerves, motor and sensory changes
  • Nephropathy: Renal dysfunction related to changes in the basement membrane of the glomerulus
  • Infections: Increase in frequency and severity r/t decreased blood flow and altered neutrophil function
  • Foot ulcers: Decreased wound healing r/t vascular insufficiency, unnoticed wounds r/t neuropathy and decreased perception of pain
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Metabolic changes when insufficient insulin is released

A
  • Hyperglycemia: inc. blood sugar
  • Glycosuria: sugar in the urine
  • Polyuria: increased urine
  • Polyphagia: increased hunger
  • Polydipsia: increased thirst
  • Lipolysis: Fat breakdown
  • Ketosis: ketones cannot be removed efficiently and build up
  • Acidosis: Liver cannot remove all waste products
  • Protein in urine
  • Elevated BUN
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

What is Type 1 DM?

A
  • Rapid onset
  • Usually diagnosed in younger years
  • Caused by autoimmune destruction of BETA cells in the pancreas
  • Pts need INSULIN replacement
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

What is Type 2 DM?

A
  • Usually occurs in mature adults
  • Has a slow and progressive onset
  • Decreased insulin sensitivity in peripheral cells (insulin resistance)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Hypoglycemia
Signs and Symptoms

A

Blood glucose < 70mg/dL
* Shakiness
* Dizziness
* Sweating
* Hunger
* Tachycardia
* Inability to concentrate
* Confusion
* Irritability or moodiness

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Signs of DANGEROUS complications of
Hyperglycemia

A
  • Fruity breath (ketones are being excreted through the lungs)
  • Dehydration
  • Fast, deep breaths (Kussmaul’s respirations)
  • Loss of orientation, coma
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Lifespan Considerations for Antidiabetic Agents
In Children

A
  • Monitor closely for hyper- and hypoglycemia
  • Insulin often needs to be diluted due to small dosages
  • Two nurse check for insulin
  • Challenging to treat in teams d/t noncompliance and changing hormones
  • Team approach - family, patient, teachers, coaches, etc.
  • Metformin is the only oral DM drug approved
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Lifespan Considerations for Antidiabetic Agents
In Adults

A
  • Two nurse check for insulin
  • Emphasize diet and exercise
  • Caution about OTC, herbal, and alternative therapies
  • Insulin is best choice in pregnancy and lactation
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Lifespan Considerations for Antidiabetic Agents
In Older Adults

A
  • Two nurse checks for insulin
  • Underlying problems complicate diabetic therapy (i.e. poor vision)
  • Dietary deficiencies lead to fluctuations in glucose levels
  • Renal or hepatic impairment may make oral agents not feasible
  • Emphasize diet, exercise, skin, and foot care
  • More likely to experience end organ damage (i.e. kidneys)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Insulin
Mechanism of Action

A
  • Hormone that promotes the storage of the body’s fuels
  • Facilitates the transport of various metabolites across cell membranes
  • Stimulates the synthesis of glycogen from glucose
  • Reacts with specific receptor sites on the cell membranes
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Insulin
Indications

A
  • Type 1 DM
  • Type 2 DM in patients whose diabetes cannot be controlled by diet or other agents
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Insulin
Contraindications

A

Absolute:
* Hypoglycemia

Caution:
* Pregnancy and lactation (monitor closely)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

Insulin
Adverse Effects

A
  • Hypoglycemia and ketoacidosis
  • Local injection site reactions
  • Decreased blood potassium levels
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

Insulin
Drug Interactions

A

Will need increased insulin doses
* Beta Blockers
* Thiazide Diuretics
* Glucocorticosteroids
* Glucose altering medications (salicylates, alcohol, oral antidiabetic agents, beta blockers)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

Regular Insulin
Onset, peak time, duration

A

Onset: 30-60 min
Peak: 2-4 hours
Duration: 6-12 hours

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

NPH Insulin
Onset, peak time, duration

A

Onset: 1-1.5 hours
Peak: 4-12 hours
Duration: 24 hours

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

Inhaled Insulin
Onset, peak time, duration

A

Onset: 12-15 minutes
Peak: 60 minutes
Duration: 2.5-3 hours

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

Lispro Insulin
Onset, peak time, duration

A

Onset: < 15 min
Peak: 30-90 min
Duration: 2-5 hours

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

Aspart Insulin
Onset, peak time, duration

A

Onset: 10-20 min
Peak: 1-3 hours
Duration: 3-5 hours

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

Glargine Insulin
Onset, peak time, duration

A

Onset: 60-70 min
Peak: NONE
Duration: 24 hours

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
**Glulisine Insulin** Onset, peak time, duration
**Onset:** 2-5 min **Peak:** 30-90 min **Duration:** 2 hours
26
**Detemir Insulin** Onset, peak time, duration
**Onset:** 1-2 hours **Peak:** 3-6 hours **Duration:** 5.7-23.3 hours
27
**Insulin** Assessment
**History:** * Check for hypoglycemia, pregnancy, lactation * Assess nutritional intake and activity level * Assess history of blood sugar regulation **Physical:** * Skin lesions * Orientation and reflexes * Pulse and BP * Respiratory status **Labs:** * Blood glucose within the hour * Monitor High A1C * Urinalysis * BMP
28
**Insulin** Nursing Diagnoses/ Conclusions
* Glucose and electrolyte imbalance risk *(r/t use of insulin and underlying disease)* * Malnutrition risk *(r/t changes in glucose transport)* * Altered sensory perception *(r/t glucose levels)* * Infection risk *(r/t injections and disease processes)* * Injury risk *(r/t potential hypoglycemia, hyperglycemia, and injection technique)* * Coping impairment *(r/t diagnosis and need for injection therapy)* * Knowledge deficit
29
**Insulin** Implementation/ Patient Teaching
* Educate on foot care, drug-drug interactions, nerve sensitivities * Ensure patient is following dietary and exercise regimen and using good hygiene practices * Gently rotate the vial, never shake * Select a site free of bruising and scarring; rotate site each time * Give maintenance doses by subq injection or inhaled routes only * Monitor pt for signs and symptoms of hypoglycemia, especially during peak times * Always verify name of insulin being given * During stress - insulin may need to be increased * Do not mix insulins in the same injection * Store in a cool place away from sunlight * Make sure patient eats when taking insulin * Protect pt from infection * Instruct pts receiving betablockers to monitor glucose levels closely
30
**Sulfonylureas** Drug Names
**Tolbutamide**: first generation - *inc. risk of CV disease* **Glipizide** - 2nd generation **Glyburide** 2nd generation *2nd generation has fewer drug interactions and longer duration*
31
**Sulfonylureas** Mechanism of Action
* Stimulate insulin release from the beta cells in the pancreas * Improve binding to insulin receptors
32
**Sulfonylureas** Indications
* Adjunct to diet and exercise for Type 2 DM
33
**Sulfonylureas** Contraindications
**Absolute:** * Allergy * Diabetic complications * Type 1 DM * Pregnancy and lactation
34
**Sulfonylureas** Adverse Effects
* Hypoglycemia * GI distress * Allergic skin reactions
35
**Sulfonylureas** Drug Interactions
* Beta Blockers * Alcohol * Herbal remedies
36
**Biguanides** Drug Name
**Metformin**
37
**Biguanides: Metformin** Mechanism of Action
* Decreases production and increases uptake of glucose * Lowers both basal and postprandial glucose levels * Decreases hepatic glucose production * Improves insulin sensitivity of peripheral cells
38
**Biguanides: Metformin** Indication
* 1st line treatment for Type 2 DM *Can be used off label for PCOS*
39
**Biguanides: Metformin** Contraindications
**All will increase risk of lactic acidosis** **Absolute:** * Hypersensitivity * Metabolic acidosis * Severe renal impairment **Cautions:** * Hepatic impairment * Excessive alcohol intake * NPO status * Radiologic contrast * Age 65 and older * Hypoxic state *(HF, resp. distress)*
40
**Biguanides: Metformin** Adverse Effects
* **Black Box warning:** Lactic acidosis *(rare)* * GI effects * Dizziness, headache * Upper Respiratory Infections * Taste disturbances
41
**Biguanides: Metformin** Drug Interactions
* Alcohol * Carbonic anhydrase * Iodine containing contrast media *(can lead to kidney failure)*
42
**DPP-4 Inhibitor** Drug Name
**Sita"-gliptin"**
43
**DPP-4 Inhibitor: Sitagliptin** Mechanism of Action
* Slow inaction of incretin hormones: increase insulin release and decrease glucagon release
44
**DPP-4 Inhibitor: Sitagliptin** Indication
* Adjunct to diet and exercise for Type 2 DM
45
**DPP-4 Inhibitor: Sitagliptin** Contraindications
**Absolute:** * Allergy * Type 1 DM or DKA **Caution:** * Renal impairment
46
**DPP-4 Inhibitor: Sitagliptin** Adverse Effects
**Rarely reported**
46
**Meglitinides** Indication
* Adjunct to diet and exercise in Type 2 diabetes
46
**DPP-4 Inhibitor: Sitagliptin** Drug Interactions
* Other medications that lower blood glucose
47
**Meglitinides** Mechanism of Action
* Stimulates insulin release from the beta cells in the pancreas
48
**Meglitinides** Drug Names
**"-glinide"** Repa**glinide** Nate**glinide**
49
**Meglitinides** Contraindications
**Absolute:** * Hypersensitivity * Type 1 DM or DKA
50
**Meglitinides** Adverse Effects
* Upper Respiratory Infections * Headache * Arthralgias * Nausea, diarrhea * Hypoglycemia
51
**Meglitinides** Drug Interactions
**Numerous**
52
**SGLT-2 Inhibitors** Drug Name
**"-gliflozin"** **Canagliflozin**
53
**SGLT-2 Inhibitors: Canagliflozin** Mechanism of Action
* Blocks co-transporter system so glucose is not reabsorbed but is lost in the urine
54
**SGLT-2 Inhibitors: Canagliflozin** Indication
* Adjunct to diet and exercise in Type 2 DM *(Research being done for Type 1 DM - not FDA approved)*
55
**SGLT-2 Inhibitors: Canagliflozin** Contraindications
**Absolute:** * Type 1 DM or DKA * Severe renal impairment * Pregnancy *(2nd and 3rd trimester: can affect fetal kidney development)*
56
**SGLT-2 Inhibitors: Canagliflozin** Adverse Effects
* Dehydration and Hypotension * UTIs * Genital fungal infections * DKA * Lower Limb amputations *(esp in patients with vascular disorder)*
57
**SGLT-2 Inhibitors: Canagliflozin** Drug Interactions
* Numerous: Rifampin
58
**Thiazolidinediones** Drug Name
**"-glitazone"** **Pioglitazone**
59
**Thiazolidinediones: Pioglitazone** Mechanism of Action
* Decrease insulin resistance in peripheral cells and liver * Increase responsiveness to insulin
60
**Thiazolidinediones: Pioglitazone** Indication
* Adjunct to diet and exercise in Type 2 DM
61
**Thiazolidinediones: Pioglitazone** Contraindications
**Absolute:** * Mild to moderate HF **Cautions:** * Liver impairment
62
**Thiazolidinediones: Pioglitazone** Adverse Effects
* Upper Respiratory Infections * Headaches, muscle pain * Increased Total Cholesterol * Rapid weight gain and edema
63
**Thiazolidinediones: Pioglitazone** Drug Interactions
**Numerous** Other Antidiabetic medications
64
**GLP-1 Agonists** Drug Names
**"-glutide" and "-natide"** **Semaglutide** **Exanatide**
65
**GLP-1 Agonists** Mechanism of Action
* Increase insulin release * Decrease glucagon release * Slow down GI emptying
66
**GLP-1 Agonists** Indication
* Adjunct to diet and exercise in Type 2 DM * Reduce risk of major CV events in Type 2 DM
67
**GLP-1 Agonists** Contraindications
* Type 1 DM or DKA * Pregnancy or lactation
68
**GLP-1 Agonists** Adverse Effects
* GI effects * Pancreatitis
69
**GLP-1 Agonists** Drug Interactions
* Other antidiabetic medications * Oral medications: effects may be slowed
70
**Noninsulin Antidiabetic Agents** Assessment
**History:** * Assess for contraindications and cautions * Assess activity level and nutrition intake **Physical:** * Baseline complete physical assessment * Look for any skin lesions **Labs:** * Blood glucose levels * Urinalysis * Renal and hepatic function tests
71
**Noninsulin Antidiabetic Agents** Nursing Diagnoses/ Conclusions
* Hyperglycemia risk *(r/t diabetes mellitus disease process)* * Hypoglycemia risk *(r/t dosing of antidiabetic agents)* * Coping impairment *(r/t diagnosis and therapy)* * Knowledge deficit
72
**Noninsulin Antidiabetic Agents** Implementation/ Patient Teaching
* Administer the drug as prescribed in relationship to meals *(short acting insulin immediately before meals)* * Ensure patient is following diet and exercise modifications * Monitor nutritional status * Monitor response carefully: Blood glucose * Monitor patients during times of trauma, pregnancy, or severe stress
73
**Glucose Elevating Agents** Drug Name
**Glucagon**
74
**Glucose Elevating Agent: Glucagon** Mechanism of Action
* Increases the blood glucose levels by decreasing insulin release and accelerating the breakdown of glycogen in the liver to release glucose
75
**Glucose Elevating Agent: Glucagon** Indications
* Hypoglycemia
76
**Glucose Elevating Agent: Glucagon** Contraindications
**Absolute:** * Allergy * Pregnancy **Caution:** * Lactation * Hepatic dysfunction * Renal dysfunction * Cardiac disease
77
**Glucose Elevating Agent: Glucagon** Adverse Effects
* GI Effects * Alteration of Blood Pressure
78
**Glucose Elevating Agent: Glucagon** Drug Interactions
* Anticoagulants
79
**Glucose Elevating Agent: Glucagon** Assessment
**History:** * Contraindications and cautions **Physical:** * Orientation and reflexes * Baseline pulse and BP * Lung sounds * Bowel sounds **Labs:** * Glucose levels
80
**Glucose Elevating Agent: Glucagon** Nursing Diagnoses/ Conclusions
* Risk for unstable blood glucose *(r/t ineffective dosing of the drug)* * Malnutrition risk: more than body requirements *(r/t metabolic effects)* * Malnutrition risk: less than body requirements *(r/t GI effects)* * Altered sensory perception *(r/t glucose levels)* * Knowledge Deficit
81
**Glucose Elevating Agent: Glucagon** Implementation
* Monitor blood glucose levels closely * Have insulin on standby for emergency use * Monitor nutritional status